Kewaunee Scientific (KEQU) Stock Forecast, Price & News

Kewaunee Scientific's stock was trading at $15.95 at the beginning of 2023. Since then, KEQU shares have increased by 9.4% and is now trading at $17.45.
View the best growth stocks for 2023 here.

Kewaunee Scientific saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 11,500 shares, an increase of 21.1% from the August 15th total of 9,500 shares. Based on an average daily volume of 2,400 shares, the short-interest ratio is currently 4.8 days. Approximately 0.5% of the shares of the company are short sold.
View Kewaunee Scientific's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, December 6th 2023.
View our KEQU earnings forecast.

Kewaunee Scientific Co. (NASDAQ:KEQU) released its quarterly earnings data on Thursday, August, 31st. The technology company reported $0.86 earnings per share (EPS) for the quarter. The technology company had revenue of $49.84 million for the quarter. Kewaunee Scientific had a trailing twelve-month return on equity of 10.53% and a net margin of 1.81%.

Kewaunee Scientific (NASDAQ:KEQU) pays an annual dividend of $0.76 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 55.88%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for KEQU.

5 employees have rated Kewaunee Scientific Chief Executive Officer William A. Shumaker on Glassdoor.com. William A. Shumaker has an approval rating of 100% among the company's employees. This puts William A. Shumaker in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Kewaunee Scientific investors own include Carnival Co. & (CCL), Magnachip Semiconductor (MX), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Alphabet (GOOG), KEMET (KEM), Micron Technology (MU), Energy Transfer (ET).

Kewaunee Scientific trades on the NASDAQ under the ticker symbol "KEQU."

Kewaunee Scientific's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Northern Trust Corp (10.63%), Dimensional Fund Advisors LP (6.00%), Renaissance Technologies LLC (2.76%), BlackRock Inc. (0.45%) and Acadian Asset Management LLC (0.23%). Insiders that own company stock include David S Rhind, David S Rhind, Donald F Shaw, Donald T Gardner III, Elizabeth D Phillips, John Russell, Keith M Gehl and Thomas David Hull III.
View institutional ownership trends.

Shares of KEQU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of KEQU stock can currently be purchased for approximately $17.45.

Kewaunee Scientific (NASDAQ:KEQU) has a market capitalization of $50.67 million and generates $219.21 million in revenue each year. The technology company earns $740,000.00 in net income (profit) each year or $1.36 on an earnings per share basis.

The company employs 982 workers across the globe.

Kewaunee Scientific's mailing address is 2700 W FRONT ST, STATESVILLE NC, 28677. The official website for the company is www.kewaunee.com. The technology company can be reached via phone at (704) 873-7202, via email at mikeparker@kewaunee.com, or via fax at 704-873-5160.